GH Research (GHRS) Non Operating Income (2022 - 2024)
GH Research (GHRS) recorded quarterly Non Operating Income of $3.9 million in Q1 2024, up 845.56% quarter-over-quarter from -$518000.0 in Q1 2023, and up 845.56% on a YoY basis from $408435.3 in Q2 2023.
GH Research (GHRS) Non Operating Income (2022 - 2024) Analysis & Trends
GH Research's Non Operating Income history runs 3 years deep, the most recent figure standing at $3.9 million for Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 444,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 9.35 Mn |
| 10 | GH Research | 10.10 Bn | 10.00 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 3.86 Mn |
| Mar 31, 2023 | -518,000.00 |
| Mar 31, 2022 | 2.24 Mn |